Cargando…
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
A retrospective analysis was performed to evaluate the clinical characteristics and prognostic factors in the patients with clear cell carcinoma (CCC) of the ovary. After central pathological review and scanning of the medical records of nine Japanese institutions between 1992 and 2003, a total of 2...
Autores principales: | Takano, M, Kikuchi, Y, Yaegashi, N, Kuzuya, K, Ueki, M, Tsuda, H, Suzuki, M, Kigawa, J, Takeuchi, S, Moriya, T, Sugiyama, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361284/ https://www.ncbi.nlm.nih.gov/pubmed/16641903 http://dx.doi.org/10.1038/sj.bjc.6603116 |
Ejemplares similares
-
Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
por: Takano, Masashi, et al.
Publicado: (2012) -
Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer
por: Tsuda, H, et al.
Publicado: (2004) -
Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002) -
Fluorescence polarization with FDA in leukaemic cells: a clear difference between myelogenous and lymphocytic origins.
por: Tsuda, H., et al.
Publicado: (1981) -
Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)